East Kent Hospitals University NHS Foundation Trust, Kent and Canterbury Hospital, Canterbury, Kent, United Kingdom.
Muscle Nerve. 2019 Nov;60(5):538-543. doi: 10.1002/mus.26651. Epub 2019 Aug 9.
Therapeutic ultrasound has been suggested as a treatment for carpal tunnel syndrome (CTS), but existing trial evidence is of poor quality and inconclusive.
We conducted a randomized, controlled trial of therapeutic ultrasound in mild to moderate CTS. Forty patients were treated with wrist splints plus either real or sham therapeutic ultrasound and followed for 1 year posttreatment. The primary outcome was change in symptom severity scale score. Secondary outcomes were functional status scale score, nerve conduction studies, and ultrasound imaging of the median nerve.
Both groups showed significant clinical and neurophysiological improvement at 6 and 12 months compared with baseline. There were no significant differences between groups at any time. In a multivariate analysis, the only independently significant predictors of the primary outcome were pretreatment symptom severity and additional treatments during follow-up.
We found no clinically significant benefit from ultrasound treatment for CTS.
治疗性超声已被提议作为治疗腕管综合征(CTS)的一种方法,但现有试验证据质量差且结论不确定。
我们进行了一项治疗性超声治疗轻至中度 CTS 的随机对照试验。40 名患者接受腕夹板加真实或假超声治疗,并在治疗后 1 年进行随访。主要结局是症状严重程度量表评分的变化。次要结局是功能状态量表评分、神经传导研究和正中神经超声成像。
两组在 6 个月和 12 个月时与基线相比均有显著的临床和神经生理学改善。两组在任何时候均无显著差异。在多变量分析中,主要结局的唯一独立显著预测因素是治疗前症状严重程度和随访期间的其他治疗。
我们没有发现超声治疗 CTS 有临床显著益处。